Formulary Search Results for: CALCIUM AND VITAMIN D
16.2 Specific antidotes - View Category
16.2 Specific antidotes - View Category
16.2 Specific antidotes - View Category
11.8.1.3 Sodium hyaluronate preparations - View Category
Restrictions:
Restricted to use in severe dry eyes when Blink Intensive Tears or Eyeaze are not appropriate and the addition of trehalose is desirable (corneal damage).
Prescribing Notes:
- Contains sodium hyaluronate (0.15%) and trehalose (3%)
- Preservatives: preservative-free
15.1.4.2 Non-opioid analgesics - View Category
Restrictions:
Restricted to specialist initiation.
Prescribing Notes:
In June 2013, the MHRA issued new contraindications and warnings for diclofenac following a review of the cardiovascular risk, which it states is similar to that of the selective COX-2 inhibitors. A summary of the guidance on the MHRA website is available HERE
8.3.2 Progestogens - View Category
16.2 Specific antidotes - View Category
5.1.10 Antileprotic drugs - View Category
Restrictions:
Restricted to specialist initiation.
Prescribing Notes:
For indications in dermatology please refer to section 13.10.1.2
5.1.12 Quinolones - View Category
Restrictions:
Restricted to use on the advice of a consultant microbiologist or consultant infectious disease physician for patients with acute bacterial skin and skin structure infections (ABSSSI) who have suspected or confirmed polymicrobial infection following treatment failure or when standard antibacterial therapies are not suitable.
Please note: this is a PROTECTED ANTIBIOTIC (see policy here) and relevant paper work should be completed.
Prescribing Notes:
Due to the risk of severe, disabling and potentially permanent adverse events, new restrictions apply to the prescribing of fluoroquinolones.
Please see new MHRA advice (January 2024) and NHSGGC statement (March 2024) for more details.
5.3.1.5 Other HIV combination preparations - View Category